BioCentury | Oct 3, 2013
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Chemokine CX3C motif receptor 1 (CX3CR1) Mouse studies suggest inhibiting CX3CR1 could help treat glomerulonephritis. In a mouse model of crescentic glomerulonephritis, Cx3cr1...
BioCentury | Oct 27, 2011
Cover Story

Much ado about TDO

...2,3-dioxygenase ( TDO2 ; TDO ) [ a(1) ]. Kynurenine then binds to AHR (purple crescent...
BioCentury | Oct 20, 2011
Targets & Mechanisms

Factor H complements AMD

Researchers in the EU and the U.S. have found what could be the mechanistic underpinnings of the increased risk for age-related macular degeneration in individuals carrying a common polymorphism in the gene for complement factor...
BioCentury | Mar 17, 2011
Cover Story

Imaging with aptamers

...first DNA sequence (light blue strand). A fluorophore (yellow star) and quencher molecule (dark purple crescent...
BioCentury | Oct 11, 2010
Financial News

Glythera financial update

...the total raised in the financing to £500,000 ($789,700). IP Group and University of Bath Crescent...
BioCentury | May 6, 2010
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Macrophage mannose receptor (MR) Mouse studies suggest that inhibiting MR could help treat crescentic glomerulonephritis, which can lead to end-stage kidney disease. In...
BioCentury | Dec 3, 2007
Company News

Eli Lilly, International Federation of Red Cross and Red Crescent Societies infectious news

...26). Eli Lilly and Co. (LLY), Indianapolis, Ind. International Federation of Red Cross and Red Crescent...
BioCentury | Mar 26, 2007
Company News

Eli Lilly infectious news

...in Health; the International Council of Nurses; International Federation of the Red Cross & Red Crescent...
BioCentury | Mar 23, 2007
Company News

Eli Lilly to invest $50M in TB partnership

...in Health; the International Council of Nurses; International Federation of the Red Cross & Red Crescent...
BioCentury | Dec 12, 2005
Tools & Techniques

More than meets the eye

More than meets the eye New imaging technology can provide more and better information. The angiogram on the left appears normal. However, intravascular ultrasound reveals a varying extent of atherosclerosis in two sites in the...
Items per page:
1 - 10 of 13
BioCentury | Oct 3, 2013
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Chemokine CX3C motif receptor 1 (CX3CR1) Mouse studies suggest inhibiting CX3CR1 could help treat glomerulonephritis. In a mouse model of crescentic glomerulonephritis, Cx3cr1...
BioCentury | Oct 27, 2011
Cover Story

Much ado about TDO

...2,3-dioxygenase ( TDO2 ; TDO ) [ a(1) ]. Kynurenine then binds to AHR (purple crescent...
BioCentury | Oct 20, 2011
Targets & Mechanisms

Factor H complements AMD

Researchers in the EU and the U.S. have found what could be the mechanistic underpinnings of the increased risk for age-related macular degeneration in individuals carrying a common polymorphism in the gene for complement factor...
BioCentury | Mar 17, 2011
Cover Story

Imaging with aptamers

...first DNA sequence (light blue strand). A fluorophore (yellow star) and quencher molecule (dark purple crescent...
BioCentury | Oct 11, 2010
Financial News

Glythera financial update

...the total raised in the financing to £500,000 ($789,700). IP Group and University of Bath Crescent...
BioCentury | May 6, 2010
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Macrophage mannose receptor (MR) Mouse studies suggest that inhibiting MR could help treat crescentic glomerulonephritis, which can lead to end-stage kidney disease. In...
BioCentury | Dec 3, 2007
Company News

Eli Lilly, International Federation of Red Cross and Red Crescent Societies infectious news

...26). Eli Lilly and Co. (LLY), Indianapolis, Ind. International Federation of Red Cross and Red Crescent...
BioCentury | Mar 26, 2007
Company News

Eli Lilly infectious news

...in Health; the International Council of Nurses; International Federation of the Red Cross & Red Crescent...
BioCentury | Mar 23, 2007
Company News

Eli Lilly to invest $50M in TB partnership

...in Health; the International Council of Nurses; International Federation of the Red Cross & Red Crescent...
BioCentury | Dec 12, 2005
Tools & Techniques

More than meets the eye

More than meets the eye New imaging technology can provide more and better information. The angiogram on the left appears normal. However, intravascular ultrasound reveals a varying extent of atherosclerosis in two sites in the...
Items per page:
1 - 10 of 13